Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF FEBU Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FEBU Stock Details FEBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,031	Closed	-$386K	–	3790
2025 Q1	$386K	Buy	+16,031	New	+$396K	﹤0.01%	2663

Other funds holding FEBU

GIA

Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return

NIA

NBZ Investment Advisors Knoxville, Tennessee $229M AUM 17.28% 1-Year Est. Return

AIMU

Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return

SWA

Stratos Wealth Advisors Beachwood, Ohio $1.63B AUM 16.33% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

AWAG

ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Cambridge Investment Research Advisors's FEBU Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF (FEBU) in Q2 2025, closing a stake of 16,031 shares — an estimated $386K sold.

Cambridge Investment Research Advisors first reported a position in FEBU in Q1 2025 and held it in 1 quarter. The position peaked at $386K in Q1 2025. 21 funds tracked by Wall St. Rank hold FEBU as of Q2 2025.

Cambridge Investment Research Advisors reported no remaining AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF position as of Q2 2025 after selling out during the quarter.
Cambridge Investment Research Advisors sold 16,031 AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF shares in Q2 2025, an estimated $386K.
Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF in Q1 2025 and held it in 1 quarter.
Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF position peaked at $386K in Q1 2025.
21 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.